Perspective · 11 Apr 2025
Conference abstract
Hematopoietic stem cell transplantation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
During the past 25 years, hematopoietic stem cell transplantation (HSCT) has been accepted as routine treatment for many patients with hematologic malignancies. Hematopoiesis is the process by which all cellular elements of the blood develop. This highly complex and tightly regulated biological function is characterized by the stimulation of the pluripotent hematopoietic stem cell by various glycoproteins known as hematopoietic growth factors (HGFs). Recent laboratory and clinical observations on the biology of transplantation have challenged many of the fundamental beliefs and practices established over the past quarter century. Stem cell transplants are most often used to help people with leukemia and lymphoma. They may also be used for neuroblastoma and multiple myeloma. HSCT can be described according to the relationship between the patient and the donor and by the anatomic source of stem cells. Syngenic donors represent the best source of stem cells; unlike the use of allogenic donors, there is no risk of graft versus host disease (GVHD) and unlike the use of autologous marrow, there is no risk of the stem cells been contaminated with tumor cells. The procedure of HSCT includes diagnostic tests, initial chemotherapy, granulocyte colony-stimulating factors, Hickman catheter insertion, conditioning treatment, stem cell infusion, and supportive medication. The high doses of cancer treatment that one has before a stem cell transplant can cause problems such as bleeding and an increased risk of infection. Recent research found that novel stem cell line avoids risk of introducing transplanted tumours. Sleep deprivation affects stem cells and may reduce transplant efficiency.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 25 Oct 2024
Which Human Leukocyte Antigen (HLA) are Donor-Derived T-cells Restricted to After HLA-Mismatched Hematopoietic Stem Cell Transplantation?
Article · 29 Aug 2024
Modern Techniques in Hematopoietic Stem Cell Transplantation: Advancing Donor Matching and Genomic Profiling
Opinion · 25 Sep 2023
Exploring the use of hematopoietic stem cell transplantation as a treatment for various disorders
Commentary · 26 Apr 2023
Acute lymphoblastic leukemia and hematopoietic stem cell transplantation
More from this journal
The newest in Journal of Blood Disorders & Transfusion.
Article · 8 Jun 2026
Analysis of Motivations and Barriers to Voluntary Blood Donation in the Thessalian Population: Findings from a Quantitative Study
Article · 30 Apr 2026
Cellular Neighbourhoods of Blood Formation: Understanding the Hematopoietic Microenvironment
Article · 30 Apr 2026
Erythrocyte Membrane Disorders: Structural Defects and Their Impact on Red Blood Cell Survival
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Blood Disorders & Transfusion
- SubjectHaematology
- BylineArticles whose byline prints “Amandeep Kaur”
